Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net debt changed +1705.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Revenue changed +10.8% from the comparable as-filed period.
Free-cash-flow margin changed +377 basis points from the comparable as-filed period.
Operating cash-flow margin changed +396 basis points from the comparable as-filed period.
Working capital / assets changed -675 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capital expenditure changed +26.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Debt / revenue changed +26389 basis points from the comparable as-filed period.
Current ratio changed -25.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed +13.9% from the comparable as-filed period.
Trade receivables changed +12.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed -251.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Operating income changed -0.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross profit changed +8.8% from the comparable as-filed period.
Capex / revenue changed +19 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +14.2% from the comparable as-filed period.
SBC / revenue changed +24 basis points from the comparable as-filed period.
Receivables / revenue changed +104 basis points from the comparable as-filed period.
R&D / revenue changed +40 basis points from the comparable as-filed period.
Current long-term debt changed +0.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.